2471 – 2480 of 3825
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
The Third Injection Technique Workshop in Athens (TITAN).
(
- Contribution to journal › Article
-
Mark
Occurrence of impaired fasting glucose in GH‐deficient adults receiving GH replacement compared with untreated subjects
(
- Contribution to journal › Article
- 2009
-
Mark
No association of the IRS1 and PAX4 genes with type I diabetes
(
- Contribution to journal › Article
-
Mark
Perilipin is present in islets of Langerhans and protects against lipotoxicity when overexpressed in the beta-cell line INS-1.
(
- Contribution to journal › Article
-
Mark
Hyperactivity in adrenergic signalling via alpha2A receptors contributes to human type 2 diabetes
2009) 45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes In Diabetologia 52(Suppl 1). p.108-108(
- Contribution to journal › Published meeting abstract
-
Mark
Dual effects of low and high concentrations of cAMP on glucagon secretion from mouse pancreatic A-cells
2009) 45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes In Diabetologia 52(Suppl 1). p.562-562(
- Contribution to journal › Published meeting abstract
-
Mark
Melatonin receptor signalling is involved in insulin secretion in the INS-1 832/13 beta cell line
2009) 45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes In Diabetologia 52(Suppl. 1). p.401-401(
- Contribution to journal › Published meeting abstract
-
Mark
Genetic dissection of type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
Swedish patients with type 2 diabetes show willingness-to-pay for health improvements including weight loss, reduction in hypoglycaemia and glycaemic control
2009) 45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes In Diabetologia 52. p.1039-1039(
- Contribution to journal › Published meeting abstract
-
Mark
Insulin-like growth factor-I, d3-GHR gene polymorphism, prematurity and height at start as determinants of one year growth response during high dose GH; preliminary results from the NESGA study (NESGAS)
(
- Contribution to journal › Published meeting abstract